At Inphasol, we are pushing the boundaries of what bacteriophage, or phage, can do for human health, agriculture, and industrial applications by developing next generation phage technologies. As a spinout of Texas A&M's Center for Phage Technology, we are utilizing decades of basic and applied research to harness the untapped potential of phages and utilize them for applications well beyond traditional phage therapy. Our flagship platform for protein delivery, PIPER, transforms probiotics into powerful cell factories capable of targeted in situ synthesis and delivery of an expanded range of therapeutic proteins due to our platforms unique properties.
